BioLineRx (BLRX) Return on Capital Employed Growth (3y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4,853.00 |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | 622.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 622.00 |
| Sep 30, 2025 | 42.00 |
| Jun 30, 2025 | -902.00 |
| Mar 31, 2025 | -2,932.00 |
| Dec 31, 2024 | -3,380.00 |
| Sep 30, 2024 | -7,198.00 |
| Jun 30, 2024 | -12,153.00 |
| Mar 31, 2024 | -13,403.00 |
| Dec 31, 2023 | -25,478.00 |
| Sep 30, 2023 | -2,821.00 |
| Jun 30, 2023 | 750.00 |
| Mar 31, 2023 | 2,328.00 |
| Dec 31, 2022 | 2,207.00 |
| Sep 30, 2022 | 1,093.00 |
| Jun 30, 2022 | 205.00 |
| Mar 31, 2022 | 883.00 |
| Dec 31, 2021 | 2,417.00 |
| Sep 30, 2021 | 2,864.00 |
| Jun 30, 2021 | 2,654.00 |
| Mar 31, 2021 | 1,177.00 |
| Dec 31, 2020 | -1,923.00 |
| Sep 30, 2020 | -3,066.00 |
| Jun 30, 2020 | -3,270.00 |
| Mar 31, 2020 | -2,433.00 |
| Dec 31, 2019 | -2,003.00 |
| Sep 30, 2019 | -1,203.00 |
| Jun 30, 2019 | -1,053.00 |
| Mar 31, 2019 | -1,276.00 |
| Dec 31, 2018 | -2,508.00 |
| Sep 30, 2018 | -2,659.00 |
| Jun 30, 2018 | -2,321.00 |
| Mar 31, 2018 | -1,088.00 |
| Dec 31, 2017 | 1,190.00 |
| Sep 30, 2017 | 1,017.00 |
| Jun 30, 2017 | -201.00 |
| Mar 31, 2017 | 234.00 |
| Dec 31, 2016 | 4,744.00 |